Home pageOPL • ASX
add
Opyl Ltd
Chiusura precedente
0,015 $
Intervallo giornaliero
0,015 $ - 0,015 $
Intervallo annuale
0,014 $ - 0,035 $
Cap di mercato
2,17 Mln AUD
Volume medio
199.335,00
Rapporto P/E
-
Dividendo/Prezzo
-
Borsa valori principale
ASX
Notizie del mercato finanziario
Dati finanziari
Conto economico
Entrate
Utile netto
| (AUD) | giu 2024info | Variazione Y/Y |
|---|---|---|
Entrate | 76.975,00 | -53,11% |
Spese di gestione | 421.400,00 | 55,20% |
Utile netto | -927.036,00 | -67,65% |
Margine di profitto netto | -1204,33 | -257,51% |
Utili per azione | — | — |
EBITDA | -909.055,00 | -66,48% |
Aliquota fiscale effettiva | — | — |
Stato patrimoniale
Totale attivo
Totale passivo
| (AUD) | giu 2024info | Variazione Y/Y |
|---|---|---|
Investimenti cash/breve termine | 374.645,00 | -17,27% |
Totale attivo | 411.598,00 | -41,99% |
Totale passivo | 501.758,00 | -54,93% |
Patrimonio netto totale | -90.160,00 | — |
Azioni in circolazione | 222,15 Mln | — |
Prezzo/valore contabile | ∞ | — |
Redditività dell'attivo | -556,44% | — |
Rendimento sul capitale | 2.540,24% | — |
Flusso di cassa
Flusso di cassa netto
| (AUD) | giu 2024info | Variazione Y/Y |
|---|---|---|
Utile netto | -927.036,00 | -67,65% |
Liquidità di esercizio | -738.291,00 | -58,54% |
Contanti da investimenti | -8856,00 | -7.807,14% |
Contanti da finanziamenti | 642.116,00 | 72,83% |
Flusso di cassa netto | -105.031,00 | -11,42% |
Flusso di cassa libero | -171.584,00 | 42,93% |
Informazioni
Opyl is a Melbourne-based company listed on the Australian Securities Exchange that applies artificial intelligence to improving clinical trial efficiencies. The company has two key platforms: Opin a global clinical trial recruitment platform and service as well as TrialKey a Saas software as a service platform that predicts and designs optimized clinical trial protocols, reducing the risk of failure and improving a return on investment in new and emerging medicines, devices, and diagnostics..
Opyl is a rebrand and strategic realignment from a former company known as ShareRoot, a US-based martech platform that secured rights to user-generated content on social media, predominantly used by big brands that collaborated with influencers.
Before going public in 2016, ShareRoot had previously participated in 500 Startups batch 8 and raised a round of angel investing.
ShareRoot was rebranded to Opyl in 2020 to work on technology to support the health and life sciences sector. Wikipedia
Fondazione
2013
Sito web
Dipendenti
3
